Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

about

Ultrafast Liquid Chromatographic Method Development and its Validation for Quantification of Telaprevir in Pharmaceutical Dosage Form by Using Quality by Design Approach.

P2860

Q53621473-06795BE5-BE7A-45D6-9AD5-E2EBE10F8E9D

P2860

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

Item

http://www.wikidata.org/entity/Q42280851

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

@en

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

@nl

type

Item

label

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

@en

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

@nl

prefLabel

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

@en

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

@nl

P1476

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

@en

P2093

Elisa Milano

http://www.w3.org/2001/XMLSchema#string

Gianpiero D'Offizi

http://www.w3.org/2001/XMLSchema#string

Leopoldo P Pucillo

http://www.w3.org/2001/XMLSchema#string

Marzia Montalbano

http://www.w3.org/2001/XMLSchema#string

Paolo Ascenzi

http://www.w3.org/2001/XMLSchema#string

Pasquale Narciso

http://www.w3.org/2001/XMLSchema#string

P2860

Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus

Ultra-performance liquid chromatography/tandem mass spectrometric determination of diastereomers of SCH 503034 in monkey plasma.

Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C.

Overview of therapeutic drug monitoring.

Telaprevir: a hepatitis C NS3/4A protease inhibitor.

Telaprevir: pharmacokinetics and drug interactions.

Clinical management of drug-drug interactions in HCV therapy: challenges and solutions.

Boceprevir in chronic hepatitis C infection: a perspective review.

Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection.

A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.

P304

800-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IUB.1197

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonio D'Avolio

Massimo Tempestilli

Tecla Gasperi

P577

2013-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23893913

http://www.w3.org/2001/XMLSchema#string

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

about

P2860

P2860

Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698